Prognostic features and markers for testicular cancer management

Eddy S. Leman, Mark L Gonzalgo

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Testicular neoplasm accounts for about 1% of all cancers in men. Over the last 40 years, the incidence of testicular cancer has increased in northern European male populations for unknown reasons. When diagnosed at early stage, testicular cancer is usually curable with a high survival rate. In the past three decades, successful multidisciplinary approaches for the management of testicular cancer have significantly increased patient survival rates. Utilization of tumor markers and accurate prognostic classification has also contributed to successful therapy. In this article, we highlight the most commonly used tumor markers and several potential "novel" markers for testicular cancer as part of the ongoing effort in biomarker research and discovery. In addition, this article also identifies several key prognostic features that have been demonstrated to play a role in predicting relapse. These features include tumor size, rete testis invasion, lymphovascular invasion, and tumor histology. Together with tumor markers, these prognostic factors should be taken into account for risk-adapted management of testicular cancer.

Original languageEnglish (US)
Pages (from-to)76-81
Number of pages6
JournalIndian Journal of Urology
Volume26
Issue number1
DOIs
StatePublished - Jan 1 2010
Externally publishedYes

Fingerprint

Testicular Neoplasms
Tumor Biomarkers
Survival Rate
Risk Management
Neoplasms
Histology
Biomarkers
Recurrence
Incidence
Research
Population

Keywords

  • Non-seminoma
  • Prognostic factors
  • Seminoma
  • Testicular cancer
  • Tumor markers

ASJC Scopus subject areas

  • Urology

Cite this

Prognostic features and markers for testicular cancer management. / Leman, Eddy S.; Gonzalgo, Mark L.

In: Indian Journal of Urology, Vol. 26, No. 1, 01.01.2010, p. 76-81.

Research output: Contribution to journalArticle

@article{3110ab896f3c4733ba91f71f78d7df0b,
title = "Prognostic features and markers for testicular cancer management",
abstract = "Testicular neoplasm accounts for about 1{\%} of all cancers in men. Over the last 40 years, the incidence of testicular cancer has increased in northern European male populations for unknown reasons. When diagnosed at early stage, testicular cancer is usually curable with a high survival rate. In the past three decades, successful multidisciplinary approaches for the management of testicular cancer have significantly increased patient survival rates. Utilization of tumor markers and accurate prognostic classification has also contributed to successful therapy. In this article, we highlight the most commonly used tumor markers and several potential {"}novel{"} markers for testicular cancer as part of the ongoing effort in biomarker research and discovery. In addition, this article also identifies several key prognostic features that have been demonstrated to play a role in predicting relapse. These features include tumor size, rete testis invasion, lymphovascular invasion, and tumor histology. Together with tumor markers, these prognostic factors should be taken into account for risk-adapted management of testicular cancer.",
keywords = "Non-seminoma, Prognostic factors, Seminoma, Testicular cancer, Tumor markers",
author = "Leman, {Eddy S.} and Gonzalgo, {Mark L}",
year = "2010",
month = "1",
day = "1",
doi = "10.4103/0970-1591.60450",
language = "English (US)",
volume = "26",
pages = "76--81",
journal = "Indian Journal of Urology",
issn = "0970-1591",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "1",

}

TY - JOUR

T1 - Prognostic features and markers for testicular cancer management

AU - Leman, Eddy S.

AU - Gonzalgo, Mark L

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Testicular neoplasm accounts for about 1% of all cancers in men. Over the last 40 years, the incidence of testicular cancer has increased in northern European male populations for unknown reasons. When diagnosed at early stage, testicular cancer is usually curable with a high survival rate. In the past three decades, successful multidisciplinary approaches for the management of testicular cancer have significantly increased patient survival rates. Utilization of tumor markers and accurate prognostic classification has also contributed to successful therapy. In this article, we highlight the most commonly used tumor markers and several potential "novel" markers for testicular cancer as part of the ongoing effort in biomarker research and discovery. In addition, this article also identifies several key prognostic features that have been demonstrated to play a role in predicting relapse. These features include tumor size, rete testis invasion, lymphovascular invasion, and tumor histology. Together with tumor markers, these prognostic factors should be taken into account for risk-adapted management of testicular cancer.

AB - Testicular neoplasm accounts for about 1% of all cancers in men. Over the last 40 years, the incidence of testicular cancer has increased in northern European male populations for unknown reasons. When diagnosed at early stage, testicular cancer is usually curable with a high survival rate. In the past three decades, successful multidisciplinary approaches for the management of testicular cancer have significantly increased patient survival rates. Utilization of tumor markers and accurate prognostic classification has also contributed to successful therapy. In this article, we highlight the most commonly used tumor markers and several potential "novel" markers for testicular cancer as part of the ongoing effort in biomarker research and discovery. In addition, this article also identifies several key prognostic features that have been demonstrated to play a role in predicting relapse. These features include tumor size, rete testis invasion, lymphovascular invasion, and tumor histology. Together with tumor markers, these prognostic factors should be taken into account for risk-adapted management of testicular cancer.

KW - Non-seminoma

KW - Prognostic factors

KW - Seminoma

KW - Testicular cancer

KW - Tumor markers

UR - http://www.scopus.com/inward/record.url?scp=77950582720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950582720&partnerID=8YFLogxK

U2 - 10.4103/0970-1591.60450

DO - 10.4103/0970-1591.60450

M3 - Article

VL - 26

SP - 76

EP - 81

JO - Indian Journal of Urology

JF - Indian Journal of Urology

SN - 0970-1591

IS - 1

ER -